Tumor DNA ‘valuable’ for metastatic prostate cancer prognosis
Tumor DNA profiling could be used to identify which men with metastatic prostate cancer need aggressive treatment and those who may benefit from de-escalation. A model, trained and tested on nearly 2,500 veterans with metastatic hormone-sensitive prostate cancer, found those with favorable germline profiles had a…